Skip to main content
Top
Published in: Gut Pathogens 1/2011

Open Access 01-01-2011 | Review

Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future?

Authors: Whitney P Bowe, Alan C Logan

Published in: Gut Pathogens | Issue 1/2011

Login to get access

Abstract

Over 70 years have passed since dermatologists John H. Stokes and Donald M. Pillsbury first proposed a gastrointestinal mechanism for the overlap between depression, anxiety and skin conditions such as acne. Stokes and Pillsbury hypothesized that emotional states might alter the normal intestinal microflora, increase intestinal permeability and contribute to systemic inflammation. Among the remedies advocated by Stokes and Pillsbury were Lactobacillus acidophilus cultures. Many aspects of this gut-brain-skin unifying theory have recently been validated. The ability of the gut microbiota and oral probiotics to influence systemic inflammation, oxidative stress, glycemic control, tissue lipid content and even mood itself, may have important implications in acne. The intestinal microflora may also provide a twist to the developing diet and acne research. Here we provide a historical perspective to the contemporary investigations and clinical implications of the gut-brain-skin connection in acne.
Appendix
Available only for authorised users
Literature
1.
go back to reference Uhlenhake E, Yentzer BA, Feldman SR: Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol. 2010, 9: 59-63. 10.1111/j.1473-2165.2010.00478.x.PubMedCrossRef Uhlenhake E, Yentzer BA, Feldman SR: Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol. 2010, 9: 59-63. 10.1111/j.1473-2165.2010.00478.x.PubMedCrossRef
2.
go back to reference Loney T, Standage M, Lewis S: Not just 'skin deep': psychosocial effects of dermatological-related social anxiety in a sample of acne patients. J Health Psychol. 2008, 13: 47-54. 10.1177/1359105307084311.PubMedCrossRef Loney T, Standage M, Lewis S: Not just 'skin deep': psychosocial effects of dermatological-related social anxiety in a sample of acne patients. J Health Psychol. 2008, 13: 47-54. 10.1177/1359105307084311.PubMedCrossRef
3.
go back to reference Magin P, Adams J, Heading G, Pond D, Smith W: Psychological sequelae of acne vulgaris: results of a qualitative study. Can Fam Phys. 2006, 52: 978-9. Magin P, Adams J, Heading G, Pond D, Smith W: Psychological sequelae of acne vulgaris: results of a qualitative study. Can Fam Phys. 2006, 52: 978-9.
4.
go back to reference Purvis D, Robinson E, Merry S, Watson P: Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students. J Paediat Child Health. 2006, 42: 793-6. 10.1111/j.1440-1754.2006.00979.x.CrossRef Purvis D, Robinson E, Merry S, Watson P: Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students. J Paediat Child Health. 2006, 42: 793-6. 10.1111/j.1440-1754.2006.00979.x.CrossRef
5.
go back to reference Rapp DA, Brenes GA, Feldman SR, Fleischer AB, Graham GF, Daily M, Rapp SR: Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol. 2004, 151: 183-9. 10.1111/j.1365-2133.2004.06078.x.PubMedCrossRef Rapp DA, Brenes GA, Feldman SR, Fleischer AB, Graham GF, Daily M, Rapp SR: Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol. 2004, 151: 183-9. 10.1111/j.1365-2133.2004.06078.x.PubMedCrossRef
6.
go back to reference Thomas DR: Psychosocial effects of acne. J Cutan Med Surg. 2004, 8 (Suppl. 4): 3-5.PubMed Thomas DR: Psychosocial effects of acne. J Cutan Med Surg. 2004, 8 (Suppl. 4): 3-5.PubMed
7.
go back to reference Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY: The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999, 140: 672-6. 10.1046/j.1365-2133.1999.02768.x.PubMedCrossRef Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY: The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999, 140: 672-6. 10.1046/j.1365-2133.1999.02768.x.PubMedCrossRef
8.
go back to reference Zhang H, Liao W, Chao W, Chen Q, Zeng H, Wu C: Risk factors for sebaceous gland diseases and their relationship to gastrointestinal dysfunction in Han adolescents. J Dermatol. 2008, 35: 555-61. 10.1111/j.1346-8138.2008.00523.x.PubMedCrossRef Zhang H, Liao W, Chao W, Chen Q, Zeng H, Wu C: Risk factors for sebaceous gland diseases and their relationship to gastrointestinal dysfunction in Han adolescents. J Dermatol. 2008, 35: 555-61. 10.1111/j.1346-8138.2008.00523.x.PubMedCrossRef
9.
go back to reference Stokes JH, Pillsbury DH: The effect on the skin of emotional and nervous states: theoretical and practical consideration of a gastrointestinal mechanism. Arch Dermatol Syphilol. 1930, 22: 962-93.CrossRef Stokes JH, Pillsbury DH: The effect on the skin of emotional and nervous states: theoretical and practical consideration of a gastrointestinal mechanism. Arch Dermatol Syphilol. 1930, 22: 962-93.CrossRef
10.
go back to reference Norman HJ: Lactic acid bacteria in the treatment of melancholia. Br Med J. 1909, 1: 1234-5. Norman HJ: Lactic acid bacteria in the treatment of melancholia. Br Med J. 1909, 1: 1234-5.
11.
go back to reference Phillips JGP: The treatment of melancholia by the lactic acid bacillus. J Mental Sci. 1910, 56: 422-31. Phillips JGP: The treatment of melancholia by the lactic acid bacillus. J Mental Sci. 1910, 56: 422-31.
12.
go back to reference Shera G: A special method of investigating the streptococcal and acidophilus intestinal flora: with results in fifty-three mental patients. J Mental Sci. 1930, 76: 56-65. Shera G: A special method of investigating the streptococcal and acidophilus intestinal flora: with results in fifty-three mental patients. J Mental Sci. 1930, 76: 56-65.
13.
go back to reference Lombardo L, Foti M, Ruggia O, Chiecchio A: Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010, 8: 504-8. 10.1016/j.cgh.2009.12.022.PubMedCrossRef Lombardo L, Foti M, Ruggia O, Chiecchio A: Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010, 8: 504-8. 10.1016/j.cgh.2009.12.022.PubMedCrossRef
14.
go back to reference Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J: Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010, 16: 2978-90. 10.3748/wjg.v16.i24.2978.PubMedCentralPubMedCrossRef Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J: Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010, 16: 2978-90. 10.3748/wjg.v16.i24.2978.PubMedCentralPubMedCrossRef
15.
go back to reference Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G: Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology. 2008, 47: 1223-7. 10.1093/rheumatology/ken140.PubMedCrossRef Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G: Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology. 2008, 47: 1223-7. 10.1093/rheumatology/ken140.PubMedCrossRef
16.
go back to reference Toskes PP: Bacterial overgrowth of the gastrointestinal tract. Adv Intern Med. 1993, 38: 387-407.PubMed Toskes PP: Bacterial overgrowth of the gastrointestinal tract. Adv Intern Med. 1993, 38: 387-407.PubMed
17.
go back to reference Lauritano EC, Valenza V, Sparano L, Scarpellini E, Gabrielli M, Cazzato A: Small intestinal bacterial overgrowth and intestinal permeability. Scand J Gastroenterol. 2010, 45: 1131-2. 10.3109/00365521.2010.485325.PubMedCrossRef Lauritano EC, Valenza V, Sparano L, Scarpellini E, Gabrielli M, Cazzato A: Small intestinal bacterial overgrowth and intestinal permeability. Scand J Gastroenterol. 2010, 45: 1131-2. 10.3109/00365521.2010.485325.PubMedCrossRef
18.
go back to reference Wang SX, Wu WC: Effects of psychological stress on small intestinal motility and bacteria and mucosa in mice. World J Gastroenerol. 2005, 11: 2016-21.CrossRef Wang SX, Wu WC: Effects of psychological stress on small intestinal motility and bacteria and mucosa in mice. World J Gastroenerol. 2005, 11: 2016-21.CrossRef
19.
go back to reference Addolorato G, Mirijello A, D'Angelo C, Leggio L, Ferrulli A, Abenavoli L: State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract. 2008, 62: 1063-9. 10.1111/j.1742-1241.2008.01763.x.PubMedCrossRef Addolorato G, Mirijello A, D'Angelo C, Leggio L, Ferrulli A, Abenavoli L: State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract. 2008, 62: 1063-9. 10.1111/j.1742-1241.2008.01763.x.PubMedCrossRef
20.
go back to reference Pimentel M, Hallegua D, Chow EJ, Wallace D, Bonorris G, Lin HC: Eradication of small intestinal bacterial overgrowth decreases symptoms in chronic fatigue syndrome: a double blind, randomized study. Gastroenterology. 2000, 118: A414-10.1016/S0016-5085(00)83765-8.CrossRef Pimentel M, Hallegua D, Chow EJ, Wallace D, Bonorris G, Lin HC: Eradication of small intestinal bacterial overgrowth decreases symptoms in chronic fatigue syndrome: a double blind, randomized study. Gastroenterology. 2000, 118: A414-10.1016/S0016-5085(00)83765-8.CrossRef
21.
go back to reference Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A: Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008, 6: 759-64. 10.1016/j.cgh.2008.02.054.PubMedCrossRef Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A: Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008, 6: 759-64. 10.1016/j.cgh.2008.02.054.PubMedCrossRef
22.
go back to reference Barrett JS, Canale KE, Gearry RB, Irving PM, Gibson PR: Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol. 2008, 14: 5020-4. 10.3748/wjg.14.5020.PubMedCentralPubMedCrossRef Barrett JS, Canale KE, Gearry RB, Irving PM, Gibson PR: Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World J Gastroenterol. 2008, 14: 5020-4. 10.3748/wjg.14.5020.PubMedCentralPubMedCrossRef
23.
go back to reference Ralph HJ, Volker DH, Chin J: Effects of omega-3 fatty acid deficiency on rat intestinal structure and microbiology. Asia Pac J Clin Nutr. 2004, 13 (Suppl): S79. Ralph HJ, Volker DH, Chin J: Effects of omega-3 fatty acid deficiency on rat intestinal structure and microbiology. Asia Pac J Clin Nutr. 2004, 13 (Suppl): S79.
24.
go back to reference Freeman MP: Omega-3 fatty acids in major depressive disorder. J Clin Psychiatry. 2009, 70 (Suppl): 7-11. 10.4088/JCP.8157su1c.02.PubMedCrossRef Freeman MP: Omega-3 fatty acids in major depressive disorder. J Clin Psychiatry. 2009, 70 (Suppl): 7-11. 10.4088/JCP.8157su1c.02.PubMedCrossRef
25.
go back to reference Rubin MG, Kim K, Logan AC: Acne vulgaris, mental health and omega-3 fatty acids: a report of cases. Lipids Health Dis. 2008, 7: 36-10.1186/1476-511X-7-36.PubMedCentralPubMedCrossRef Rubin MG, Kim K, Logan AC: Acne vulgaris, mental health and omega-3 fatty acids: a report of cases. Lipids Health Dis. 2008, 7: 36-10.1186/1476-511X-7-36.PubMedCentralPubMedCrossRef
26.
go back to reference Strickler A, Kolmer JA, Schamberg JF: Complement fixation in acne vulgaris. J Cutaneous Dis. 1916, 34: 166-78. Strickler A, Kolmer JA, Schamberg JF: Complement fixation in acne vulgaris. J Cutaneous Dis. 1916, 34: 166-78.
27.
go back to reference Juhlin L, Michaëlsson G: Fibrin microclot formation in patients with acne. Acta Derm Venereol. 1983, 63: 538-40.PubMed Juhlin L, Michaëlsson G: Fibrin microclot formation in patients with acne. Acta Derm Venereol. 1983, 63: 538-40.PubMed
28.
go back to reference Viana AF, Maciel IS, Dornelles FN, Figueiredo CP, Siqueira JM, Campos MM: Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide. Neuroinflammation. 2010, 7: 98-10.1186/1742-2094-7-98.CrossRef Viana AF, Maciel IS, Dornelles FN, Figueiredo CP, Siqueira JM, Campos MM: Kinin B1 receptors mediate depression-like behavior response in stressed mice treated with systemic E. coli lipopolysaccharide. Neuroinflammation. 2010, 7: 98-10.1186/1742-2094-7-98.CrossRef
29.
go back to reference Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S: Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007, 132: 913-20. 10.1053/j.gastro.2007.01.046.PubMedCrossRef Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S: Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007, 132: 913-20. 10.1053/j.gastro.2007.01.046.PubMedCrossRef
30.
go back to reference Gibbes H: Acne. Med Council. 1912, 17: 301-3. Gibbes H: Acne. Med Council. 1912, 17: 301-3.
32.
go back to reference Ketron LW, King JH: Gastrointestinal findings in acne vulgaris. JAMA. 1916, 60: 671-75.CrossRef Ketron LW, King JH: Gastrointestinal findings in acne vulgaris. JAMA. 1916, 60: 671-75.CrossRef
33.
go back to reference Khalif IL, Quigley EM, Konovitch EA, Maximova ID: Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis. 2005, 7: 838-49. 10.1016/j.dld.2005.06.008.CrossRef Khalif IL, Quigley EM, Konovitch EA, Maximova ID: Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis. 2005, 7: 838-49. 10.1016/j.dld.2005.06.008.CrossRef
34.
go back to reference Attaluri A, Jackson M, Valestin J, Rao SS: Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol. 2010, 105: 1407-11. 10.1038/ajg.2009.655.PubMedCrossRef Attaluri A, Jackson M, Valestin J, Rao SS: Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol. 2010, 105: 1407-11. 10.1038/ajg.2009.655.PubMedCrossRef
35.
go back to reference Maes M, Kubera M, Leunis JC: The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008, 29: 117-24.PubMed Maes M, Kubera M, Leunis JC: The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008, 29: 117-24.PubMed
36.
go back to reference Hillilä MT, Hämäläinen J, Heikkinen ME, Färkkilä MA: Gastrointestinal complaints among subjects with depressive symptoms in the general population. Aliment Pharmacol Ther. 2008, 28: 648-54.PubMedCrossRef Hillilä MT, Hämäläinen J, Heikkinen ME, Färkkilä MA: Gastrointestinal complaints among subjects with depressive symptoms in the general population. Aliment Pharmacol Ther. 2008, 28: 648-54.PubMedCrossRef
38.
go back to reference Logan AC, Katzman M: Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses. 2005, 64: 533-8. 10.1016/j.mehy.2004.08.019.PubMedCrossRef Logan AC, Katzman M: Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses. 2005, 64: 533-8. 10.1016/j.mehy.2004.08.019.PubMedCrossRef
39.
go back to reference Logan AC, Venket Rao A, Irani D: Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value. Med Hypotheses. 2003, 60: 915-23. 10.1016/S0306-9877(03)00096-3.PubMedCrossRef Logan AC, Venket Rao A, Irani D: Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value. Med Hypotheses. 2003, 60: 915-23. 10.1016/S0306-9877(03)00096-3.PubMedCrossRef
40.
go back to reference Knowles SR, Nelson EA, Palombo EA: Investigating the role of perceived stress on bacterial flora activity and salivary cortisol secretion: a possible mechanism underlying susceptibility to illness. Biol Psychol. 2008, 77: 132-7. 10.1016/j.biopsycho.2007.09.010.PubMedCrossRef Knowles SR, Nelson EA, Palombo EA: Investigating the role of perceived stress on bacterial flora activity and salivary cortisol secretion: a possible mechanism underlying susceptibility to illness. Biol Psychol. 2008, 77: 132-7. 10.1016/j.biopsycho.2007.09.010.PubMedCrossRef
41.
go back to reference Loveman DE, Noojin RO, Winkler CH: Comparative studies of the enteric bacterial flora in acne vulgaris. J Invest Dermatol. 1955, 25: 135-7.PubMedCrossRef Loveman DE, Noojin RO, Winkler CH: Comparative studies of the enteric bacterial flora in acne vulgaris. J Invest Dermatol. 1955, 25: 135-7.PubMedCrossRef
42.
go back to reference Holdeman LV, Good IJ, Moore WE: Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ Microbiol. 1976, 31: 359-75.PubMedCentralPubMed Holdeman LV, Good IJ, Moore WE: Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ Microbiol. 1976, 31: 359-75.PubMedCentralPubMed
43.
go back to reference Volkova LA, Khalif IL, Kabanova IN: Impact of the impaired intestinal microflora on the course of acne vulgaris. Klin Med (Mosk). 2001, 79: 39-41. Russian. Volkova LA, Khalif IL, Kabanova IN: Impact of the impaired intestinal microflora on the course of acne vulgaris. Klin Med (Mosk). 2001, 79: 39-41. Russian.
44.
go back to reference Zhang H, Yu L, Yi M, Li K: Quantitative studies on normal flora of seborrhoeic dermatitis. Chin J Dermatol. 1999, 32: 399-400. Chinese. Zhang H, Yu L, Yi M, Li K: Quantitative studies on normal flora of seborrhoeic dermatitis. Chin J Dermatol. 1999, 32: 399-400. Chinese.
46.
go back to reference Siver RH: Lactobacillus for the control of acne. J Med Soc New Jersey. 1961, 59: 52-53. Siver RH: Lactobacillus for the control of acne. J Med Soc New Jersey. 1961, 59: 52-53.
47.
go back to reference Marchetti F, Capizzi R, Tulli A: Efficacy of regulators of the intestinal bacterial flora in the therapy of acne vulgaris. Clin Ter. 1987, 122: 339-43. Italian.PubMed Marchetti F, Capizzi R, Tulli A: Efficacy of regulators of the intestinal bacterial flora in the therapy of acne vulgaris. Clin Ter. 1987, 122: 339-43. Italian.PubMed
48.
go back to reference Kim J, Ko Y, Park YK, Kim NI, Ha WK, Cho Y: Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris. Nutrition. 2010, 26: 902-9. 10.1016/j.nut.2010.05.011.PubMedCrossRef Kim J, Ko Y, Park YK, Kim NI, Ha WK, Cho Y: Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris. Nutrition. 2010, 26: 902-9. 10.1016/j.nut.2010.05.011.PubMedCrossRef
49.
go back to reference Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H: Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr. 2002, 76: 1249-55.PubMed Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H: Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr. 2002, 76: 1249-55.PubMed
50.
go back to reference Schiffrin EJ, Thomas DR, Kumar VB, Brown C, Hager C, Van't Hof MA: Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics. J Nutr Health Aging. 2007, 11: 475-9.PubMed Schiffrin EJ, Thomas DR, Kumar VB, Brown C, Hager C, Van't Hof MA: Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics. J Nutr Health Aging. 2007, 11: 475-9.PubMed
51.
go back to reference Mikelsaar M, Zilmer M: Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic. Microb Ecol Health Dis. 2009, 21: 1-27. 10.1080/08910600902815561.PubMedCentralPubMedCrossRef Mikelsaar M, Zilmer M: Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic. Microb Ecol Health Dis. 2009, 21: 1-27. 10.1080/08910600902815561.PubMedCentralPubMedCrossRef
52.
go back to reference Bowe WP, Logan AC: Clinical implications of lipid peroxidation in acne: old wine in new bottles. Lipids Health Dis. 2010, 9: 141-10.1186/1476-511X-9-141.PubMedCentralPubMedCrossRef Bowe WP, Logan AC: Clinical implications of lipid peroxidation in acne: old wine in new bottles. Lipids Health Dis. 2010, 9: 141-10.1186/1476-511X-9-141.PubMedCentralPubMedCrossRef
53.
go back to reference Fu YR, Yi ZJ, Pei JL, Guan S: Effects of Bifidobacterium bifidum on adaptive immune senescence in aging mice. Microbiol Immunol. 2010, 54: 578-83.PubMed Fu YR, Yi ZJ, Pei JL, Guan S: Effects of Bifidobacterium bifidum on adaptive immune senescence in aging mice. Microbiol Immunol. 2010, 54: 578-83.PubMed
54.
go back to reference Hacini-Rachinel F, Gheit H, Le Luduec JB, Dif F, Nancey S, Kaiserlian D: Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS One. 2009, 4: e4903-10.1371/journal.pone.0004903.PubMedCentralPubMedCrossRef Hacini-Rachinel F, Gheit H, Le Luduec JB, Dif F, Nancey S, Kaiserlian D: Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS One. 2009, 4: e4903-10.1371/journal.pone.0004903.PubMedCentralPubMedCrossRef
55.
go back to reference Cazzola M, Tompkins TA, Matera MG: Immunomodulatory impact of a synbiotic in T(h)1 and T(h)2 models of infection. Ther Adv Respir Dis. 2010, 4: 259-70. 10.1177/1753465810379009.PubMedCrossRef Cazzola M, Tompkins TA, Matera MG: Immunomodulatory impact of a synbiotic in T(h)1 and T(h)2 models of infection. Ther Adv Respir Dis. 2010, 4: 259-70. 10.1177/1753465810379009.PubMedCrossRef
56.
go back to reference Glück U, Gebbers JO: Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr. 2003, 77: 517-20.PubMed Glück U, Gebbers JO: Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr. 2003, 77: 517-20.PubMed
57.
go back to reference Peyri J: Topical bacteriotherapy of the skin. J Cutaneous Dis. 1912, 30: 688-89. Peyri J: Topical bacteriotherapy of the skin. J Cutaneous Dis. 1912, 30: 688-89.
58.
go back to reference Di Marzio L, Cinque B, De Simone C, Cifone MG: Effect of the lactic acid bacterium Streptococcus thermophilus on ceramide levels in human keratinocytes in vitro and stratum corneum in vivo. J Invest Dermatol. 1999, 113: 98-106. 10.1046/j.1523-1747.1999.00633.x.PubMedCrossRef Di Marzio L, Cinque B, De Simone C, Cifone MG: Effect of the lactic acid bacterium Streptococcus thermophilus on ceramide levels in human keratinocytes in vitro and stratum corneum in vivo. J Invest Dermatol. 1999, 113: 98-106. 10.1046/j.1523-1747.1999.00633.x.PubMedCrossRef
59.
go back to reference Di Marzio L, Centi C, Cinque B, Masci S, Giuliani M, Arcieri A: Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp Dermatol. 2003, 12: 615-20. 10.1034/j.1600-0625.2003.00051.x.PubMedCrossRef Di Marzio L, Centi C, Cinque B, Masci S, Giuliani M, Arcieri A: Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp Dermatol. 2003, 12: 615-20. 10.1034/j.1600-0625.2003.00051.x.PubMedCrossRef
60.
go back to reference Di Marzio L, Cinque B, Cupelli F, De Simone C, Cifone MG, Giuliani M: Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus. Int J Immunopathol Pharmacol. 2008, 21: 137-43.PubMed Di Marzio L, Cinque B, Cupelli F, De Simone C, Cifone MG, Giuliani M: Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus. Int J Immunopathol Pharmacol. 2008, 21: 137-43.PubMed
61.
go back to reference Pavicic T, Wollenweber U, Farwick M, Korting HC: Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. Int J Cosmet Sci. 2007, 29: 181-90. 10.1111/j.1467-2494.2007.00378.x.PubMedCrossRef Pavicic T, Wollenweber U, Farwick M, Korting HC: Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. Int J Cosmet Sci. 2007, 29: 181-90. 10.1111/j.1467-2494.2007.00378.x.PubMedCrossRef
62.
go back to reference Yamamoto A, Takenouchi K, Ito M: Impaired water barrier function in acne vulgaris. Arch Dermatol Res. 1995, 287: 214-8. 10.1007/BF01262335.PubMedCrossRef Yamamoto A, Takenouchi K, Ito M: Impaired water barrier function in acne vulgaris. Arch Dermatol Res. 1995, 287: 214-8. 10.1007/BF01262335.PubMedCrossRef
63.
go back to reference Hancox JG, Sheridan SC, Feldman SR, Fleischer AB: Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. Int J Dermatol. 2004, 43: 6-11. 10.1111/j.1365-4632.2004.01828.x.PubMedCrossRef Hancox JG, Sheridan SC, Feldman SR, Fleischer AB: Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. Int J Dermatol. 2004, 43: 6-11. 10.1111/j.1365-4632.2004.01828.x.PubMedCrossRef
64.
go back to reference Gueniche A, Benyacoub J, Philippe D, Bastien P, Kusy N, Breton L: Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Eur J Dermatol. 2010, 20: 731-7.PubMed Gueniche A, Benyacoub J, Philippe D, Bastien P, Kusy N, Breton L: Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Eur J Dermatol. 2010, 20: 731-7.PubMed
65.
go back to reference Guéniche A, Bastien P, Ovigne JM, Kermici M, Courchay G, Chevalier V: Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp Dermatol. 2010, 19: e1-8.PubMedCrossRef Guéniche A, Bastien P, Ovigne JM, Kermici M, Courchay G, Chevalier V: Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp Dermatol. 2010, 19: e1-8.PubMedCrossRef
66.
go back to reference Lee WJ, Jung HD, Lee HJ, Kim BS, Lee SJ, Kim do W: Influence of substance-P on cultured sebocytes. Arch Dermatol Res. 2008, 300: 311-6. 10.1007/s00403-008-0854-1.PubMedCrossRef Lee WJ, Jung HD, Lee HJ, Kim BS, Lee SJ, Kim do W: Influence of substance-P on cultured sebocytes. Arch Dermatol Res. 2008, 300: 311-6. 10.1007/s00403-008-0854-1.PubMedCrossRef
67.
go back to reference Al-Ghazzewi FH, Tester RF: Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro. Int J Cosmet Sci. 2010, 32: 139-42. 10.1111/j.1468-2494.2009.00555.x.PubMedCrossRef Al-Ghazzewi FH, Tester RF: Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro. Int J Cosmet Sci. 2010, 32: 139-42. 10.1111/j.1468-2494.2009.00555.x.PubMedCrossRef
68.
go back to reference Kang BS, Seo JG, Lee GS, Kim JH, Kim SY, Han YW: Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. J Microbiol. 2009, 47: 101-9. 10.1007/s12275-008-0179-y.PubMedCrossRef Kang BS, Seo JG, Lee GS, Kim JH, Kim SY, Han YW: Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. J Microbiol. 2009, 47: 101-9. 10.1007/s12275-008-0179-y.PubMedCrossRef
69.
go back to reference Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ: Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. J Drugs Dermatol. 2006, 5: 868-70.PubMedCentralPubMed Bowe WP, Filip JC, DiRienzo JM, Volgina A, Margolis DJ: Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. J Drugs Dermatol. 2006, 5: 868-70.PubMedCentralPubMed
70.
go back to reference Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S: The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun. 2008, 76: 4163-75. 10.1128/IAI.00188-08.PubMedCentralPubMedCrossRef Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S: The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun. 2008, 76: 4163-75. 10.1128/IAI.00188-08.PubMedCentralPubMedCrossRef
71.
72.
go back to reference Saunders AM: The bacillus acidophilus treatment. Institution Q. 1924, 15: 85-8. Saunders AM: The bacillus acidophilus treatment. Institution Q. 1924, 15: 85-8.
73.
go back to reference Hawk PB, Knowles FC, Rehfuss ME, Clarke JA: The use of baker's yeast in diseases of the skin and of the gastrointestinal tract. JAMA. 1917, 69: 1243-47.CrossRef Hawk PB, Knowles FC, Rehfuss ME, Clarke JA: The use of baker's yeast in diseases of the skin and of the gastrointestinal tract. JAMA. 1917, 69: 1243-47.CrossRef
74.
go back to reference Generoso SV, Viana M, Santos R, Martins FS, Machado JA, Arantes RM: Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch Microbiol. 2010, 192: 477-84. 10.1007/s00203-010-0574-8.PubMedCrossRef Generoso SV, Viana M, Santos R, Martins FS, Machado JA, Arantes RM: Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch Microbiol. 2010, 192: 477-84. 10.1007/s00203-010-0574-8.PubMedCrossRef
75.
go back to reference Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG: The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008, 43: 164-74. 10.1016/j.jpsychires.2008.03.009.PubMedCrossRef Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG: The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008, 43: 164-74. 10.1016/j.jpsychires.2008.03.009.PubMedCrossRef
76.
go back to reference Girard SA, Bah TM, Kaloustian S, Lada-Moldovan L, Rondeau I, Tompkins TA: Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Br J Nutr. 2009, 102: 1420-5. 10.1017/S0007114509990766.PubMedCrossRef Girard SA, Bah TM, Kaloustian S, Lada-Moldovan L, Rondeau I, Tompkins TA: Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Br J Nutr. 2009, 102: 1420-5. 10.1017/S0007114509990766.PubMedCrossRef
77.
go back to reference Wall R, Ross RP, Shanahan F, O'Mahony L, Kiely B, Quigley E: Impact of administered bifidobacterium on murine host fatty acid composition. Lipids. 2010, 45: 429-36. 10.1007/s11745-010-3410-7.PubMedCrossRef Wall R, Ross RP, Shanahan F, O'Mahony L, Kiely B, Quigley E: Impact of administered bifidobacterium on murine host fatty acid composition. Lipids. 2010, 45: 429-36. 10.1007/s11745-010-3410-7.PubMedCrossRef
78.
go back to reference Puch F, Samson-Villeger S, Guyonnet D, Blachon JL, Rawlings AV, Lassel T: Consumption of functional fermented milk containing borage oil, green tea and vitamin E enhances skin barrier function. Exp Dermatol. 2008, 17: 668-74. 10.1111/j.1600-0625.2007.00688.x.PubMedCrossRef Puch F, Samson-Villeger S, Guyonnet D, Blachon JL, Rawlings AV, Lassel T: Consumption of functional fermented milk containing borage oil, green tea and vitamin E enhances skin barrier function. Exp Dermatol. 2008, 17: 668-74. 10.1111/j.1600-0625.2007.00688.x.PubMedCrossRef
79.
go back to reference Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN: Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004, 558: 263-75. 10.1113/jphysiol.2004.063388.PubMedCentralPubMedCrossRef Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN: Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004, 558: 263-75. 10.1113/jphysiol.2004.063388.PubMedCentralPubMedCrossRef
80.
go back to reference Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X: Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010, 139: 2102-2112.e1. 10.1053/j.gastro.2010.06.063.PubMedCrossRef Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X: Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010, 139: 2102-2112.e1. 10.1053/j.gastro.2010.06.063.PubMedCrossRef
81.
go back to reference Shen Q, Shang N, Pinglan L: In vitro and in vivo antioxidant activity of Bifidobacterium animalis 01 isolated from centenarians. Curr Microbiol 2010. Shen Q, Shang N, Pinglan L: In vitro and in vivo antioxidant activity of Bifidobacterium animalis 01 isolated from centenarians. Curr Microbiol 2010.
82.
go back to reference Li W, Dowd SE, Scurlock B, Acosta-Martinez V, Lyte M: Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav. 2009, 96: 557-67. 10.1016/j.physbeh.2008.12.004.PubMedCrossRef Li W, Dowd SE, Scurlock B, Acosta-Martinez V, Lyte M: Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav. 2009, 96: 557-67. 10.1016/j.physbeh.2008.12.004.PubMedCrossRef
83.
go back to reference Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG: Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010, 170: 1179-88. 10.1016/j.neuroscience.2010.08.005.PubMedCrossRef Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG: Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010, 170: 1179-88. 10.1016/j.neuroscience.2010.08.005.PubMedCrossRef
84.
go back to reference Verdú EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W: Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut. 2006, 55: 182-90.PubMedCentralPubMedCrossRef Verdú EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W: Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut. 2006, 55: 182-90.PubMedCentralPubMedCrossRef
85.
go back to reference Collins S, Verdu E, Denou E, Bercik P: The role of pathogenic microbes and commensal bacteria in irritable bowel syndrome. Dig Dis. 2009, 27 (Suppl 1): 85-9. 10.1159/000268126.PubMedCrossRef Collins S, Verdu E, Denou E, Bercik P: The role of pathogenic microbes and commensal bacteria in irritable bowel syndrome. Dig Dis. 2009, 27 (Suppl 1): 85-9. 10.1159/000268126.PubMedCrossRef
86.
go back to reference Herpfer I, Katzev M, Feige B, Fiebich BL, Voderholzer U, Lieb K: Effects of substance P on memory and mood in healthy male subjects. Hum Psychopharmacol. 2007, 22: 567-73. 10.1002/hup.876.PubMedCrossRef Herpfer I, Katzev M, Feige B, Fiebich BL, Voderholzer U, Lieb K: Effects of substance P on memory and mood in healthy male subjects. Hum Psychopharmacol. 2007, 22: 567-73. 10.1002/hup.876.PubMedCrossRef
87.
go back to reference Lieb K, Walden J, Grunze H, Fiebich BL, Berger M, Normann C: Serum levels of substance P and response to antidepressant pharmacotherapy. Pharmacopsychiatry. 2004, 37: 238-9. 10.1055/s-2004-832599.PubMedCrossRef Lieb K, Walden J, Grunze H, Fiebich BL, Berger M, Normann C: Serum levels of substance P and response to antidepressant pharmacotherapy. Pharmacopsychiatry. 2004, 37: 238-9. 10.1055/s-2004-832599.PubMedCrossRef
88.
go back to reference Teitelman G, Joh TH, Reis DJ: Linkage of the brain-skin-gut axis: islet cells originate from dopaminergic precursors. Peptides. 1981, 2 (Suppl 2): 157-68. 10.1016/0196-9781(81)90026-7.PubMedCrossRef Teitelman G, Joh TH, Reis DJ: Linkage of the brain-skin-gut axis: islet cells originate from dopaminergic precursors. Peptides. 1981, 2 (Suppl 2): 157-68. 10.1016/0196-9781(81)90026-7.PubMedCrossRef
89.
go back to reference Bowe WP, Joshi SS, Shalita AR: Diet and acne. J Am Acad Dermatol. 2010, 63: 124-41. 10.1016/j.jaad.2009.07.043.PubMedCrossRef Bowe WP, Joshi SS, Shalita AR: Diet and acne. J Am Acad Dermatol. 2010, 63: 124-41. 10.1016/j.jaad.2009.07.043.PubMedCrossRef
90.
go back to reference Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA: A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr. 2007, 86: 107-15.PubMed Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA: A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr. 2007, 86: 107-15.PubMed
91.
go back to reference Rouhani P, Berman B, Rouhani G: Acne improves with a popular, low glycemic diet from South Beach. J Am Acad Dermatol. 2009, 60 (suppl): P706. Rouhani P, Berman B, Rouhani G: Acne improves with a popular, low glycemic diet from South Beach. J Am Acad Dermatol. 2009, 60 (suppl): P706.
92.
go back to reference Pearson S, Schmidt M, Patton G, Dwyer T, Blizzard L, Otahal P, Venn A: Depression and insulin resistance: cross-sectional associations in young adults. Diabetes Care. 2010, 33: 1128-33. 10.2337/dc09-1940.PubMedCentralPubMedCrossRef Pearson S, Schmidt M, Patton G, Dwyer T, Blizzard L, Otahal P, Venn A: Depression and insulin resistance: cross-sectional associations in young adults. Diabetes Care. 2010, 33: 1128-33. 10.2337/dc09-1940.PubMedCentralPubMedCrossRef
93.
go back to reference Timonen M, Salmenkaita I, Jokelainen J, Laakso M, Härkönen P, Koskela P, Meyer-Rochow VB, Peitso A, Keinänen-Kiukaanniemi S: Insulin resistance and depressive symptoms in young adult males: findings from Finnish military conscripts. Psychosom Med. 2007, 69: 723-8. 10.1097/PSY.0b013e318157ad2e.PubMedCrossRef Timonen M, Salmenkaita I, Jokelainen J, Laakso M, Härkönen P, Koskela P, Meyer-Rochow VB, Peitso A, Keinänen-Kiukaanniemi S: Insulin resistance and depressive symptoms in young adult males: findings from Finnish military conscripts. Psychosom Med. 2007, 69: 723-8. 10.1097/PSY.0b013e318157ad2e.PubMedCrossRef
94.
go back to reference Kleerebezem M, Vaughan EE: Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol. 2009, 63: 269-90. 10.1146/annurev.micro.091208.073341.PubMedCrossRef Kleerebezem M, Vaughan EE: Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol. 2009, 63: 269-90. 10.1146/annurev.micro.091208.073341.PubMedCrossRef
95.
go back to reference Burcelin R: Intestinal microflora, inflammation, and metabolic diseases. Abstract 019, Keystone Symposia - Diabetes Whistler, British Columbia, Canada; 2010. Burcelin R: Intestinal microflora, inflammation, and metabolic diseases. Abstract 019, Keystone Symposia - Diabetes Whistler, British Columbia, Canada; 2010.
96.
go back to reference Cani PD, Delzenne NM: Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opinion Pharmacol. 2009, 9: 737-43. 10.1016/j.coph.2009.06.016.CrossRef Cani PD, Delzenne NM: Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opinion Pharmacol. 2009, 9: 737-43. 10.1016/j.coph.2009.06.016.CrossRef
97.
go back to reference Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O: Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009, 58: 1091-103. 10.1136/gut.2008.165886.PubMedCentralPubMedCrossRef Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O: Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009, 58: 1091-103. 10.1136/gut.2008.165886.PubMedCentralPubMedCrossRef
98.
go back to reference Schiffrin EJ, Parlesak A, Bode C, Bode JC, van't Hof MA, Grathwohl D: Probiotic yogurt in the elderly with intestinal bacterial overgrowth: endotoxaemia and innate immune functions. Br J Nutr. 2009, 101: 961-6. 10.1017/S0007114508055591.PubMedCrossRef Schiffrin EJ, Parlesak A, Bode C, Bode JC, van't Hof MA, Grathwohl D: Probiotic yogurt in the elderly with intestinal bacterial overgrowth: endotoxaemia and innate immune functions. Br J Nutr. 2009, 101: 961-6. 10.1017/S0007114508055591.PubMedCrossRef
99.
go back to reference Wei B, Pang Y, Zhu H, Qu L, Xiao T, Wei HC, Chen HD, He CD: The epidemiology of adolescent acne in North East China. J Eur Acad Dermatol Venereol. 2010, 24: 953-7. 10.1111/j.1468-3083.2010.03590.x.PubMedCrossRef Wei B, Pang Y, Zhu H, Qu L, Xiao T, Wei HC, Chen HD, He CD: The epidemiology of adolescent acne in North East China. J Eur Acad Dermatol Venereol. 2010, 24: 953-7. 10.1111/j.1468-3083.2010.03590.x.PubMedCrossRef
100.
go back to reference Jung JY, Yoon MY, Min SU, Hong JS, Choi YS, Suh DH: The influence of dietary patterns on acne vulgaris in Koreans. Eur J Dermatol. 2010, Jung JY, Yoon MY, Min SU, Hong JS, Choi YS, Suh DH: The influence of dietary patterns on acne vulgaris in Koreans. Eur J Dermatol. 2010,
101.
go back to reference Ghodsi SZ, Orawa H, Zouboulis CC: Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. 2009, 129: 2136-41. 10.1038/jid.2009.47.PubMedCrossRef Ghodsi SZ, Orawa H, Zouboulis CC: Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. 2009, 129: 2136-41. 10.1038/jid.2009.47.PubMedCrossRef
102.
go back to reference Goran ML, Gower BA: Longitudinal study on pubertal insulin resistance. Diabetes. 2001, 50: 2444-50. 10.2337/diabetes.50.11.2444.PubMedCrossRef Goran ML, Gower BA: Longitudinal study on pubertal insulin resistance. Diabetes. 2001, 50: 2444-50. 10.2337/diabetes.50.11.2444.PubMedCrossRef
103.
go back to reference Adebamowo CA, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA: Milk consumption and acne in teenaged boys. J Am Acad Dermatol. 2008, 58: 787-93. 10.1016/j.jaad.2007.08.049.PubMedCentralPubMedCrossRef Adebamowo CA, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA: Milk consumption and acne in teenaged boys. J Am Acad Dermatol. 2008, 58: 787-93. 10.1016/j.jaad.2007.08.049.PubMedCentralPubMedCrossRef
104.
go back to reference Adebamowo CA, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA, et al: Milk consumption and acne in adolescent girls. Dermatol Online J. 2006, 12: 1.PubMed Adebamowo CA, Spiegelman D, Berkey CS, Danby FW, Rockett HH, Colditz GA, et al: Milk consumption and acne in adolescent girls. Dermatol Online J. 2006, 12: 1.PubMed
105.
go back to reference Adebamowo CA, Spiegelman D, Danby FW, Frazier AL, Willett WC, Holmes MD: High school dietary dairy intake and teenage acne. J Am Acad Dermatol. 2005, 52: 207-14. 10.1016/j.jaad.2004.08.007.PubMedCrossRef Adebamowo CA, Spiegelman D, Danby FW, Frazier AL, Willett WC, Holmes MD: High school dietary dairy intake and teenage acne. J Am Acad Dermatol. 2005, 52: 207-14. 10.1016/j.jaad.2004.08.007.PubMedCrossRef
106.
go back to reference Melnik BC, Schmitz G: Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol. 2009, 18: 833-41. 10.1111/j.1600-0625.2009.00924.x.PubMedCrossRef Melnik BC, Schmitz G: Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol. 2009, 18: 833-41. 10.1111/j.1600-0625.2009.00924.x.PubMedCrossRef
107.
go back to reference Ben-Amitai D, Laron Z: J Eur Acad Dermatol Venereol. 2010. Ben-Amitai D, Laron Z: J Eur Acad Dermatol Venereol. 2010.
108.
go back to reference Quadros E, Landzert NM, LeRoy S, Gasparini F, Worosila G: Colonic absorption of insulin-like growth factor I in vitro. Pharm Res. 1994, 11: 226-30. 10.1023/A:1018999106684.PubMedCrossRef Quadros E, Landzert NM, LeRoy S, Gasparini F, Worosila G: Colonic absorption of insulin-like growth factor I in vitro. Pharm Res. 1994, 11: 226-30. 10.1023/A:1018999106684.PubMedCrossRef
109.
go back to reference Kang SH, Kim JU, Imm JY, Oh S, Kim SH: The effects of dairy processes and storage on insulin-like growth factor-I (IGF-I) content in milk and in model IGF-I-fortified dairy products. J Dairy Sci. 2006, 89: 402-9. 10.3168/jds.S0022-0302(06)72104-X.PubMedCrossRef Kang SH, Kim JU, Imm JY, Oh S, Kim SH: The effects of dairy processes and storage on insulin-like growth factor-I (IGF-I) content in milk and in model IGF-I-fortified dairy products. J Dairy Sci. 2006, 89: 402-9. 10.3168/jds.S0022-0302(06)72104-X.PubMedCrossRef
110.
go back to reference Benton D, Williams C, Brown A: Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr. 2007, 61: 355-61. 10.1038/sj.ejcn.1602546.PubMedCrossRef Benton D, Williams C, Brown A: Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr. 2007, 61: 355-61. 10.1038/sj.ejcn.1602546.PubMedCrossRef
111.
go back to reference Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM: A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009, 1 (1): 6-10.1186/1757-4749-1-6.PubMedCentralPubMedCrossRef Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM: A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009, 1 (1): 6-10.1186/1757-4749-1-6.PubMedCentralPubMedCrossRef
112.
go back to reference Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al: Assessment of psychotropic-like properties of a probiotic formulation ( Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2010. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al: Assessment of psychotropic-like properties of a probiotic formulation ( Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2010.
113.
go back to reference Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR: Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009, 29: 508-18. 10.1111/j.1365-2036.2008.03911.x.PubMedCrossRef Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR: Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009, 29: 508-18. 10.1111/j.1365-2036.2008.03911.x.PubMedCrossRef
114.
go back to reference O'Brien ME, Anderson H, Kaukel E, O'Byrne K, Pawlicki M, Von Pawel J: SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. Ann Oncol. 2004, 15: 906-14.PubMedCrossRef O'Brien ME, Anderson H, Kaukel E, O'Byrne K, Pawlicki M, Von Pawel J: SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. Ann Oncol. 2004, 15: 906-14.PubMedCrossRef
115.
go back to reference Narciso JC: Some psychological aspects of dermatosis. J Consult Psychol. 1952, 16: 199-201. 10.1037/h0057104.PubMedCrossRef Narciso JC: Some psychological aspects of dermatosis. J Consult Psychol. 1952, 16: 199-201. 10.1037/h0057104.PubMedCrossRef
116.
go back to reference Lucas CJ, Ojha AB: Personality and acne. J Psychosom Res. 1963, 7: 41-3. 10.1016/0022-3999(63)90050-3.PubMedCrossRef Lucas CJ, Ojha AB: Personality and acne. J Psychosom Res. 1963, 7: 41-3. 10.1016/0022-3999(63)90050-3.PubMedCrossRef
117.
go back to reference Wright ET, Kyle NL, Gunter R: Personality test configurations in acne vulgaris. Percept Motor Skills. 1970, 30: 191-201.PubMedCrossRef Wright ET, Kyle NL, Gunter R: Personality test configurations in acne vulgaris. Percept Motor Skills. 1970, 30: 191-201.PubMedCrossRef
118.
go back to reference Polenghi MM, Zizak S, Molinari E: Emotions and acne. Dermatol Psychosom. 2002, 3: 20-5. 10.1159/000051359.CrossRef Polenghi MM, Zizak S, Molinari E: Emotions and acne. Dermatol Psychosom. 2002, 3: 20-5. 10.1159/000051359.CrossRef
119.
go back to reference Blackburn CRB: A physician's prospect of the aetiology of acne. Australasian J Dermatol. 1951, 1: 112-17. 10.1111/j.1440-0960.1951.tb01411.x.CrossRef Blackburn CRB: A physician's prospect of the aetiology of acne. Australasian J Dermatol. 1951, 1: 112-17. 10.1111/j.1440-0960.1951.tb01411.x.CrossRef
120.
go back to reference Kaymak Y, Taner E, Taner Y: Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents. Int J Dermatol. 2009, 48: 41-6. 10.1111/j.1365-4632.2009.03806.x.PubMedCrossRef Kaymak Y, Taner E, Taner Y: Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents. Int J Dermatol. 2009, 48: 41-6. 10.1111/j.1365-4632.2009.03806.x.PubMedCrossRef
121.
go back to reference Mulder MM, Sigurdsson V, van Zuuren EJ, Klaassen EJ, Faber JA, de Wit JB, van Vloten WA: Psychosocial impact of acne vulgaris. evaluation of the relation between a change in clinical acne severity and psychosocial state. Dermatology. 2001, 203: 124-30. 10.1159/000051726.PubMedCrossRef Mulder MM, Sigurdsson V, van Zuuren EJ, Klaassen EJ, Faber JA, de Wit JB, van Vloten WA: Psychosocial impact of acne vulgaris. evaluation of the relation between a change in clinical acne severity and psychosocial state. Dermatology. 2001, 203: 124-30. 10.1159/000051726.PubMedCrossRef
122.
go back to reference Ng CH, Tam MM, Celi E, Tate B, Schweitzer I: Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Australas J Dermatol. 2002, 43: 262-8. 10.1046/j.1440-0960.2002.00612.x.PubMedCrossRef Ng CH, Tam MM, Celi E, Tate B, Schweitzer I: Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Australas J Dermatol. 2002, 43: 262-8. 10.1046/j.1440-0960.2002.00612.x.PubMedCrossRef
123.
go back to reference Winkler UH, Ferguson H, Mulders JA: Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol. Contraception. 2004, 69: 469-76. 10.1016/j.contraception.2003.12.017.PubMedCrossRef Winkler UH, Ferguson H, Mulders JA: Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol. Contraception. 2004, 69: 469-76. 10.1016/j.contraception.2003.12.017.PubMedCrossRef
124.
go back to reference Marqueling AL, Zane LT: Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2007, 26: 210-20. 10.1016/j.sder.2008.03.005.PubMedCrossRef Marqueling AL, Zane LT: Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2007, 26: 210-20. 10.1016/j.sder.2008.03.005.PubMedCrossRef
125.
go back to reference Musso G, Gambino R, Cassader M: Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Curr Opin Lipidol. 2010, 21: 76-83. 10.1097/MOL.0b013e3283347ebb.PubMedCrossRef Musso G, Gambino R, Cassader M: Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Curr Opin Lipidol. 2010, 21: 76-83. 10.1097/MOL.0b013e3283347ebb.PubMedCrossRef
126.
go back to reference Musso G, Gambino R, Cassader M: Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?. Diabetes Care. 2010, 33: 2277-84. 10.2337/dc10-0556.PubMedCentralPubMedCrossRef Musso G, Gambino R, Cassader M: Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?. Diabetes Care. 2010, 33: 2277-84. 10.2337/dc10-0556.PubMedCentralPubMedCrossRef
127.
go back to reference Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J: Acne vulgaris: a disease of Western civilization. Arch Dermatol. 2002, 138: 1584-90. 10.1001/archderm.138.12.1584.PubMedCrossRef Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J: Acne vulgaris: a disease of Western civilization. Arch Dermatol. 2002, 138: 1584-90. 10.1001/archderm.138.12.1584.PubMedCrossRef
128.
go back to reference Benno Y, Suzuki K, Suzuki K, Narisawa K, Bruce WR, Mitsuoka T: Comparison of the fecal microflora in rural Japanese and urban Canadians. Microbiol Immunol. 1986, 30: 521-32.PubMedCrossRef Benno Y, Suzuki K, Suzuki K, Narisawa K, Bruce WR, Mitsuoka T: Comparison of the fecal microflora in rural Japanese and urban Canadians. Microbiol Immunol. 1986, 30: 521-32.PubMedCrossRef
129.
go back to reference Benno Y, Endo K, Miyoshi H, Okuda T, Koishi H, Mitsuoka T: Effect of rice fiber on human fecal microflora. Microbiol Immunol. 1989, 33: 435-40.PubMedCrossRef Benno Y, Endo K, Miyoshi H, Okuda T, Koishi H, Mitsuoka T: Effect of rice fiber on human fecal microflora. Microbiol Immunol. 1989, 33: 435-40.PubMedCrossRef
130.
go back to reference Brinkworth GD, Noakes M, Clifton PM, Bird AR: Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr. 2009, 101: 1493-502. 10.1017/S0007114508094658.PubMedCrossRef Brinkworth GD, Noakes M, Clifton PM, Bird AR: Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr. 2009, 101: 1493-502. 10.1017/S0007114508094658.PubMedCrossRef
131.
go back to reference Shinohara K, Ohashi Y, Kawasumi K, Terada A, Fujisawa T: Effect of apple intake on fecal microbiota and metabolites in humans. Anaerobe. 2010, 16: 510-5. 10.1016/j.anaerobe.2010.03.005.PubMedCrossRef Shinohara K, Ohashi Y, Kawasumi K, Terada A, Fujisawa T: Effect of apple intake on fecal microbiota and metabolites in humans. Anaerobe. 2010, 16: 510-5. 10.1016/j.anaerobe.2010.03.005.PubMedCrossRef
132.
go back to reference Toossi P, Farshchian M, Malekzad F, Mohtasham N, Kimyai-Asadi A: Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. Drugs Dermatol. 2008, 7: 1149-52. Toossi P, Farshchian M, Malekzad F, Mohtasham N, Kimyai-Asadi A: Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. Drugs Dermatol. 2008, 7: 1149-52.
133.
go back to reference Maffeis L, Veraldi S: Minocycline in the treatment of acne: latest findings. G Ital Dermatol Venereol. 2010, 145: 425-9.PubMed Maffeis L, Veraldi S: Minocycline in the treatment of acne: latest findings. G Ital Dermatol Venereol. 2010, 145: 425-9.PubMed
134.
go back to reference Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG: Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008, 22: 2416-26. 10.1096/fj.07-102723.PubMedCrossRef Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG: Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008, 22: 2416-26. 10.1096/fj.07-102723.PubMedCrossRef
Metadata
Title
Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future?
Authors
Whitney P Bowe
Alan C Logan
Publication date
01-01-2011
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2011
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/1757-4749-3-1

Other articles of this Issue 1/2011

Gut Pathogens 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.